Health
Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19 – News-Medical.Net
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School…

Reviewed by Emily Henderson, B.Sc.Nov 12 2020
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
The study, a collaboration between the university’s Department of Psychiatry and…
-
Noosa News10 hours ago
’Lethal new opioids’ prompt Wide Bay pill testing call
-
General24 hours ago
Housing affordability. The crisis the major parties are too scared to fix
-
General23 hours ago
Don’t use defence as bargaining chip in US tariff negotiations, warns former PM John Howard
-
General12 hours ago
‘We are here for you’: PM to bring help to flood zones